blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0519099

EP0519099 - Direct compression cyclophosphamide tablet [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  19.01.1996
Database last updated on 11.09.2024
Most recent event   Tooltip08.08.2008Change - applicantpublished on 10.09.2008  [2008/37]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [2008/37]For all designated states
Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154 / US
Former [1992/52]For all designated states
BRISTOL-MYERS SQUIBB COMPANY
345 Park Avenue
New York, N.Y. 10154-0037 / US
Inventor(s)01 / Gallian, Claude E.
4011 Frame Road
Newburgh Indiana 47630 / US
02 / Williams, Charles
deceased
deceased / US
[1992/52]
Representative(s)Kinzebach, Werner, et al
Reitstötter, Kinzebach & Partner Patentanwälte Postfach 86 06 49
81633 München / DE
[N/P]
Former [1992/52]Kinzebach, Werner, Dr., et al
Patentanwälte Reitstötter, Kinzebach und Partner Postfach 86 06 49
D-81633 München / DE
Application number, filing date91110086.519.06.1991
[1992/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0519099
Date:23.12.1992
Language:EN
[1992/52]
Search report(s)(Supplementary) European search report - dispatched on:EP14.01.1992
ClassificationIPC:A61K31/675, A61K9/20
[1992/52]
CPC:
A61K9/286 (EP,US); A61K31/675 (EP,US); A61K9/2059 (EP,US);
A61K9/2866 (EP,US); A61P35/00 (EP); A61K9/2095 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1992/52]
TitleGerman:Direktkomprimierte Cyclophosphamidtablette[1992/52]
English:Direct compression cyclophosphamide tablet[1992/52]
French:Comprimé de cyclophosphamide à compression directe[1992/52]
File destroyed:20.04.2002
Examination procedure14.05.1993Examination requested  [1993/29]
19.04.1995Despatch of communication of intention to grant (Approval: )
27.09.1995Despatch of communication that the application is refused, reason: formalities examination [1996/10]
09.10.1995Application refused, date of legal effect [1996/10]
Fees paidRenewal fee
14.06.1993Renewal fee patent year 03
11.06.1994Renewal fee patent year 04
01.05.1995Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0298666  (AMERICAN HOME PROD [US])
 [A]  - STN INTERNATIONAL INFORMATION SERVICES DATABASE: CHEMICAL ABSTRACTS, vol. 101, no. 6, 1984, accession no. 43474d, Columbus, Ohio, US; T. WAGNER et al.: "Bioavailability of cyclophosphamida from oral formulations", & EUR. J. CLIN. PHARMACOL., 26(2), 269-70
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.